Widyaningrum I and Dewi Melani Hariyadi and Esti Hendradi (2017) Anti-Inflammatory Evaluation of NLC (Nanostructured Lipid Carriers) Meloxicam In-Vivo. International Journal of Drug Delivery Technology, 7 (4). pp. 327-331. ISSN 0975-4415

	Text (FULLTEXT (EH)) C-3 fixed.pdf Download (4MB)
	Text (SIMILARITY 28-Oct-2018 (EH)) Result Bukti C-03.pdf Download (2MB)
	Text (PEER REVIEW (EH)) Rev C-3.pdf Download (1MB)
	Text (FULLTEXT (DMH)) C13.pdf Download (1MB)
	Text (SIMILARITY 11-Jun-2019 (DMH)) C-13 Anti-Inflammatory Evaluation of NLC (Nanostructured Lipid Carriers) Meloxicam In-Vivo.pdf Download (1MB)
	Text (PEER REVIEW (DMH)) C-13 Reviewer.pdf Download (2MB)
	Text (KORESPONDENSI (DMH)) Korespondensi GB2020 C-13.pdf Download (134kB)

Abstract

Objective: The aim of this research study was to investigate the anti-inflammatory effect of NLC meloxicam. NLC contains solid and liquid lipid. Monostearin as solid lipid and Miglyol 808 as liquid lipid. Methods : NLC meloxicam was repared using emulsification methodwith three different lipid ratio. . NLC meloxicam was prepared and characterized for measuring the pH, viscocity, particle size, and entrapment efficiency. The rat paw edema test was performed to evaluate the antiinflammatory activity of three formulations NLC meoxicam. Results : based on research result shows that the smaller the solid lipid concentrations, particle size is the larger, the greater viscosity, thus increasing occlusive NLC to the skin. The third formula hasthe greatest solid lipid concentration shows the smallest AUC value but once in a statistical test known to be significantly different from the three formulas. Conclusions : NLC meloxicam showed that it had anti-inflammatoryeffectiveness.

Actions (login required)

View Item